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Abstract
Cardiac surgeons during this pandemic crisis have a responsibility to ensure that essential elective cardiac operations
are provided at their centers to the public, at the same time, they have to face administrative demands as well as the
infection prevention guidelines and restrictions to protect themselves and their patients. Here, we describe the patient
and procedures characteristics that we recommend to protect our patients and the healthcare workers.
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1. Introduction

A

Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) outbreak has
declared a public health emergency of international concern by the WHO since January 2020.
On March 2nd, 2020, the Ministry of Health in
Saudi Arabia conﬁrmed the ﬁrst case of COVID
-19 disease caused by the SARS_CoV-2 virus in
the Saudi Arabia Kingdom [1,2]. As of April 10th,
2020, the Kingdom had almost 5000 conﬁrmed
cases [3,4]. The rapid, exponential increase in
conﬁrmed cases makes the prevention and control of coronavirus disease (COVID-19) extremely
challenging. The clinical manifestations of
COVID-19 are mainly respiratory; however, some
patients may present with non-speciﬁc cardiac
manifestation [3]. Furthermore, the issue which
becomes the focus of the constant debate is what
we shall do with the cardiac surgical patients on
the waiting list?

So what is the impact of COVID-19 disease
outbreak on cardiac surgery? Cardiac surgery
practice is not a business as usual. This unprecedented crisis affects cardiac surgery units in many
ways. It limits intensive care unit (ICU) beds and
ventilation sites; a necessity to postpone elective
and/or complex cardiac surgeries; shortage of
healthcare workers and sick healthcare staff. It has
also impacted the clinical meetings (e.g., limiting the
number of attendees in heart-team meetings); were
necessary decisions taken for patients on the waiting
list and in house patients. However, we do still have
the moral, and responsibility obligation, to ensure
that the essential cardiac services are provided to
the general public to the best of our knowledge. At
the same time, the broader burden of those procedures on the healthcare system and healthcare
workers must be minimized in times of COVID-19.

2. Which Cardiac Operations Should Perform?
The COVID-19 pandemic puts health services in
Saudi Arabia and all over the world under escalating pressure with an increasing number of
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infected individuals. While decisions on whether or
not to perform cardiac surgery will be more
comfortable in the early phase of the pandemic,
when ICU beds are still available, However,
continued escalation of the pandemic, will make
decisions on having surgery more difﬁcult. The
question which put itself, shall we stop all the
elective cases, and for how long? If not, which group
of patients should be offered the surgical care, while
taking the full consideration of protecting the patient and the staff from the spread of COVID-19
virus.
Following the WHO declaration, the Kingdom of
Saudi Arabia proclaimed a formal advisory to cancel
elective surgeries throughout the Kingdom. The
concerns were elective procedures might contribute
to the spreading of the COVID-19 virus within the
healthcare facilities [4]. The patient can both spread
but also be infected by staff or other patients. S
transmission is both ways. The lack of the clear
directive on how to prioritize and maintain the
cardiac surgery services to our patients, the American College of Surgeons (ACS) issued their
recommendation regarding the prioritizations of the
elective cardiac surgery as below:
The ACS bulletin stated the following speciﬁc
recommendations [7].“Each hospital, health system,
and surgeon should thoughtfully review all scheduled elective procedures with a plan to minimize,
postpone, or cancel electively scheduled operations,
endoscopies, or other invasive procedures until we
have passed the predicted inﬂection point in the
exposure graph and can be conﬁdent that our health
care infrastructure can support a potentially rapid
and overwhelming uptick in critical patient care
needs.”
2.1. Emergency and in-house urgent cardiac
surgery, on whom should we operate?
There is no doubt and no disagreement within the
international cardiac surgical communities that patients who present or in-hospital with cardiac pathology, which necessitates emergency intervention,
will undergo surgery. Patients with acute type A
aortic dissection, acute heart failure due to a severe
coronary artery or valvular heart disease, and patients with the acute coronary syndrome in case of
severe coronary artery disease (e.g., severe left main
trunk stenosis, severe triple vessel disease with high
SYNTAX score) who are not eligible for conservative
or interventional treatment should be operated on.
This may be true also for younger patients with
symptomatic severe aortic valve stenosis, left-sided
endocarditis with a severe valve defect and/or large
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mobile vegetation, large ascending aortic aneurysm
(>6 cm in diameter), in whom the delay of the surgery will have signiﬁcant morbidity and mortality.
Fig. 1.
2.2. Elective patients: how should we manage their
care?
One must realize that cardiac surgery units have a
responsibility to the patient, but also the healthcare
workers and the broader health care service in a
region/country. Until the pandemic situation is
brought under control, patients with elective cardiac
procedures should be postponed for a few weeks to
minimize their exposure to the hospital environment. Patients with cardiac illness contracted
COVID-19 often have a poor prognosis [5]. Therefore, developing COVID-19 after cardiac surgery
will associate high mortality. The cardiac center
should provide pathways of care and telecommunication, were patients on the waiting list for elective cardiac surgery will have access to their doctors.
The patients will be reassured, and their medications should be prescribed. In the case of a patient
on the waiting list is deteriorated, early recognition
is encouraged. Patients will have the direct access to
their doctors and the cardiac clinic coordinators
through the virtual clinic, to report any deterioration
in their health related to their cardiac condtion.
Arrangement will be done to be admitted to the
hospital after COVID-19 testing. Fig. 1.
2.3. COVID19 disease and the use of ECMO
The Initiation of Extra Corporeal Membrane
Oxygenation (ECMO) for the COVID-19 patients
with severe respiratory failure may result in decreases in lymphocyte numbers and immunity
function, which can be associated with increased
severity of COVID-19. A report published online in
The Lancet Respiratory Medicine Journal by Dr.
Brandon M. Henry from Cincinnati Children's
Hospital Medical centre in Ohio urges caution when
using ECMO in patients with COVID-19, especially
in the face of lymphopenia [6]. Ruan et al. reported
signiﬁcantly higher interleukin-6 concentrations in
COVID-19 non-survivors compared with survivors.
Elevated IL-6 levels in the lung induced by ECMO
inversely correlated with survival in children and
adults [7]. Brandon et al. performed a pooled analysis of the early reports of the use of ECMO in Acute
Respiratory Distress Syndrome (ARDS) due to
coronavirus disease when compared to the Middle
East Respiratory Syndrome -Related Coronavirus
(MERS-CoV) patients receiving ECMO. The
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Fig. 1. Minimizing exposure to COVID-19 teams and patients.

COVID-19 patients seem to have substantially
higher mortality (94.1% vs. 65.0%) [8,9]. Therefore
based on the available data, the beneﬁt of ECMO in
this group of patients is very doubtful. Given the
limited beneﬁts and higher risk of virus transmission to the healthcare staff, we should not support the use of ECMO for the COVID-19 ARDS
patients.

3. How to Protect Healthcare Workers and
Patients?
The Kingdom of Saudi Arabia Ministry of Health
and Ministry of the national guard, issued awareness guidelines on March 17th, 2020 to protect the
public. However, the healthcare workers among the
highest risk groups of contracting infection with
COVID-19 [10].
My personal experience during the SARS
outbreak in the Prince of Wales Hospital in Hong
Kong, two of my collegues, who are senior doctors,
were among the ﬁrst group contracted the SARS
virus during the outbreak in the hospital [10,11].
Furthermore, our experience with the MERS-CoV,
at two tertiary care hospitals in Saudi Arabia, three
out of eleven ICU critically ill patients with MERSCoVid- ARDS were healthcare workers. Precautions
in the interactions between patients and healthcare
workers are of high priority. Therefore, we put forward the following recommendation:
1. Staff management should arrange to separate health
workers/surgeons into teams so that possible quarantines

will apply to one group within each division rather than the
division as a whole, which would lead to the closure of the
entire service.
2. COVID-19 is spreading by droplets and contact [2] and not
principally an airborne. Therefore, the Center for Disease
Control and Prevention (CDC) recommends the use of
masks, gowns, pairs of gloves, during the contacts with all
patients. However, The strict adherence to use all the protective water-impermeable gown, gloves, face mask (N95)
and face shield are strongly recommended throughout the
peri-operative period for the suspected and the conﬁrmed
cases of COVID-19, undergoing cardiac surgery.
3. Operative theatre doors should be closed at all times and a
negative pressure rooms should be optimized. After surgery
and before leaving, contaminated equipments must be left in
the OR and discarded into a special container.
4. Healthcare workers must focus on meticulous hand hygiene,
avoiding contaminating workspaces, and should clean
workspaces and personal items frequently.

4. Conclusions
The COVID-19 pandemic puts cardiac surgery
services all over the world under increasing pressure. Cardiac surgeons and associated healthcare
staffs are confronted with a novel virus and disease
could leads to considerable uncertainty. It is
imperative to provide a clear direction and a decision making process on whether or not a cardiac
surgery service should be provided. We have
thoughtfully weighed the risk of delaying surgical
care with the risk of exposing the patient to the
hospital environment and the risk of developing
COVID-19, and this in the context of a healthcare

system under extreme pressure. It should be
recognized that healthcare workers are of high risk
for exposing themselves to the COVID-19 virus and
it puts healthcare workers and their family members
at higher risk of infection. Hospitals must provide
maximum protective equipment for healthcare
workers to protect themselves. Patients can only be
cared for if healthcare workers have peace of mind,
stay safe and healthy.
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